Juno Therapeutics, Inc.;The Government of The United States of America, as represented by The Secretary, Department of Health and Human Services
发明人:
申请号：
EP16196664.3
公开号：
EP3189843A1
申请日:
2006.01.26
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
Methods for modulating responsiveness to increased oxygen levels in an at-risk subject identifying an at-risk subject； and before exposing the identified at-risk subject to an increased amount of oxygen, administering to the at-risk subject an anti-inflammatory agent wherein the responsiveness of the at-risk subject to said increased amount of oxygen is modulated as compared to the responsiveness of the at-risk subject to said increased amount of oxygen in the absence of said anti-inflammatory.
